Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 2/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | ACSL1 | P33121 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4742894 | 0.82 | MAOA (0.36) | DRD2DRD3MAOAMAOBACSL1 | |
| SCHEMBL9056290 | 0.74 | ACSL1 (0.40) | MAOAMAOBACSL1 | |
| SCHEMBL9057696 | 0.74 | ACSL1 (0.40) | MAOAMAOBACSL1 | |
| SCHEMBL1672256 | 0.73 | MAOA (0.47) | MAOAMAOBACSL1 | |
| SCHEMBL83906 | 0.71 | MAOA (0.48) | MAOAMAOBACSL1 | |
| SCHEMBL4298022 | 0.70 | MAOA (0.47) | MAOAMAOBACSL1 | |
| SCHEMBL27551469 | 0.70 | DRD2 (0.46) | DRD2DRD3HTR2AKCNH2TAAR1 | |
| SCHEMBL4742922 | 0.70 | HTR6 (0.41) | DRD3HTR2AMAOAMAOBHTR1A | |
| SCHEMBL2313646 | 0.69 | MAOA (0.46) | MAOAMAOBACSL1 | |
| SCHEMBL11506362 | 0.69 | MAOA (0.46) | MAOAMAOBACSL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008113814-A1 | ORGANIC MOLYBDENUM COMPOUNDS, USE THEREOF AS FRICTION- MODIFIERS AND LUBRICATING COMPOSITIONS | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2008-09-25 | — | — | WO | disclosed |